Literature DB >> 2009787

Daytime hypertension in obstructive sleep apnea. Prevalence and contributing risk factors.

R P Millman1, S Redline, C C Carlisle, A R Assaf, P D Levinson.   

Abstract

We examined the prevalence of daytime hypertension in a modern sample of patients with obstructive sleep apnea (OSA) and assessed the relative risk factors contributing to the development of hypertension in this disorder. Daytime hypertension was present in 92 (45 percent) of 206 male and female patients with OSA. Stepwise logistic regression revealed that only age and body mass index (BMI) were predictors of hypertension in this population. A subsample of 152 male patients with OSA was then compared to 904 men identified from a geographically and ethnically similar general population. When one controlled for age and BMI, the prevalence of hypertension in the two groups was the same except for those aged 25 to 44 years who were markedly obese (BMI greater than 31 kg/m2). In this group, 47 percent of the patients with OSA were hypertensive vs 26 percent of control subjects (p less than 0.05). Our data suggest that the high prevalence of hypertension in OSA is primarily related to age and the excess obesity seen in these patients. In morbidly obese young patients with OSA, factors directly related to OSA may also be contributing to the development of hypertension. With increasing age, other competitive risks may obscure any independent effect that OSA may exert.

Entities:  

Mesh:

Year:  1991        PMID: 2009787     DOI: 10.1378/chest.99.4.861

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  32 in total

Review 1.  Pediatric origins of adult lung diseases. 3: the genesis of adult sleep apnoea in childhood.

Authors:  F McNamara; C E Sullivan
Journal:  Thorax       Date:  2000-11       Impact factor: 9.139

Review 2.  Sleep apnoea and hypertension: proof at last?

Authors:  J R Stradling; J C Pepperell; R J Davies
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

Review 3.  Sleep . 6: obstructive sleep apnoea/hypopnoea syndrome and hypertension.

Authors:  G V Robinson; J R Stradling; R J O Davies
Journal:  Thorax       Date:  2004-12       Impact factor: 9.139

4.  Positive pressure on neck reduces baroreflex response to apnoea.

Authors:  V Lepicovska; P Novak; D Drozen; Z Fabian
Journal:  Clin Auton Res       Date:  1992-02       Impact factor: 4.435

5.  Obstructive sleep apnea and ischemic heart disease in southwestern US veterans: implications for clinical practice.

Authors:  Carol M Baldwin; Iris R Bell; Stefano Guerra; Stuart F Quan
Journal:  Sleep Breath       Date:  2005-09       Impact factor: 2.816

6.  Is there a bidirectional relationship between obesity and sleep-disordered breathing?

Authors:  Stuart F Quan; Rohit Budhiraja; Sairam Parthasarathy
Journal:  J Clin Sleep Med       Date:  2008-06-15       Impact factor: 4.062

7.  Which aspects of breathing during sleep influence the overnight fall of blood pressure in a community population?

Authors:  J R Stradling; C Barbour; J Glennon; B A Langford; J H Crosby
Journal:  Thorax       Date:  2000-05       Impact factor: 9.139

8.  The effect of one night of continuous positive airway pressure therapy on oxidative stress and antioxidant defense in hypertensive patients with severe obstructive sleep apnea.

Authors:  Mohammed A Alzoghaibi; Ahmed S Bahammam
Journal:  Sleep Breath       Date:  2011-05-13       Impact factor: 2.816

9.  Physical activity and sedentary time in persons with obstructive sleep apnea and overweight enrolled in a randomized controlled trial for enhanced physical activity and healthy eating.

Authors:  Helena Igelström; Margareta Emtner; Eva Lindberg; Pernilla Asenlöf
Journal:  Sleep Breath       Date:  2013-03-28       Impact factor: 2.816

10.  Lower BMI is a predictor of obstructive sleep apnea in elderly Thai hypertensive patients.

Authors:  Kittisak Sawanyawisuth; Jarin Chindaprasirt; Vichai Senthong; Pattarapong Makarawate; Panita Limpawattana; Aornchuma Domthong; Songkwan Silaruks; Somchit Chumjan
Journal:  Sleep Breath       Date:  2013-02-27       Impact factor: 2.816

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.